Second, no study has compared two modalities of RAGE inhibition in experimental ARDS to date, and our findings support similar beneficial effects of sRAGE and anti-RAGE mAb on lung injury and AFC. This evidence concerns the gene AGER and acute respiratory distress syndrome.